It’s feasible to bring home at least some of the COVID-positive Australians stranded in India. Here’s how we can do it while keeping infection risk at a minimum.
While the results are very promising, it has only been tested in mice. Human clinical trials will take some time to complete before we know whether a drug could become available.
Insights of neuroscientist Ian McGilchrist, philosopher Nel Noddings and physicist Ursula Franklin help centre students and our collective future in debates about education and technology.
The United States and Canada have approved the Pfizer vaccine for adolescents aged 12–15. The evidence so far tells us it works well and is safe for this age group.
The mental health crisis occurring in tandem with COVID-19 has stressed resources and stretched service waitlists into years. There is an urgent need for prevention strategies, not just treatment.
Isabelle Brocas, USC Dornsife College of Letters, Arts and Sciences
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
As the Indian variant becomes more prevalent within our borders, anti-South Asian sentiment is also growing, putting the community at a higher risk of hate crimes.
Donald E Miller, USC Dornsife College of Letters, Arts and Sciences
A scholar of the Rwandan genocide argues that while a genocide and a pandemic are very different, the experiences of Rwanda’s survivors may provide lessons on how to heal from pandemic trauma.
Vaccination rates for COVID-19 have been lower than desired for herd immunity, or when enough people become immune for new infections to stop. What will life look like without it?
The Pfizer COVID-19 vaccine was recently approved for adolescents ages 12-15. Vaccination is essential to protect children from serious illness and quicken return to normal life.
Full population-level protection against COVID-19 will require most adolescents and children to be vaccinated. There are ethical arguments for encouraging vaccination uptake through vaccine mandates.
Exploring the history of quarantine hotels reveals ambivalences and inequities that continue to fuel debates over their effectiveness in the era of COVID-19.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand